1,2,3-Propanetriol,2-(dihydrogen phosphate), sodium salt (1:2)
- 中文别名:beta-甘油磷酸钠(五水); 甘油-2-磷酸二钠盐五水合物
- 中文释义:β-甘油磷酸钠;beta-甘油磷酸钠(五水)
- 英文别名:beta-Glycerophosphoric acid disodium salt;
Disodium β-glycerophosphate pentahydrate
- CAS No.:819-83-0
- 分子式:
C3H9O6P.2Na
- 分子量:306.11
- 精确分子量:288.02000
- PSA:159.61000
- MDL:MFCD00002135
- InChI:InChI=1/C3H9O6P/c4-1-3(2-5)9-10(6,7)8/h3-5H,1-2H2,(H2,6,7,8)/p-2
- 分子结构式:
物化性质
- 外观与性状:
- 白色至奶油色结晶粉末
- 熔点:
- 102-104 °C(lit.)
- 沸点:
- 485.5ºC at 760 mmHg
- 闪点:
- 247.4ºC
- 水溶解性:
- 易溶
- 存储条件/存储方法:
保持容器密封,储存在阴凉,干燥的地方
- 稳定性相关:
常温常压下稳定,避免氧化物接触
- 其它信息:
1. 性状:未确定
2. 密度(g/mL,25/4℃):未确定
3. 相对蒸汽密度(g/mL,空气=1):未确定
4. 熔点(ºC):102-104°C
5. 沸点(ºC,常压):未确定
6. 沸点(ºC,5.2kPa):未确定
7. 折射率:未确定
8. 闪点(ºC):未确定
9. 比旋光度(º):未确定
10. 自燃点或引燃温度(ºC):未确定
11. 蒸气压(kPa,25ºC):未确定
12. 饱和蒸气压(kPa,60ºC):未确定
13. 燃烧热(KJ/mol):未确定
14. 临界温度(ºC):未确定
15. 临界压力(KPa):未确定
16. 油水(辛醇/水)分配系数的对数值:未确定
17. 爆炸上限(%,V/V):未确定
18. 爆炸下限(%,V/V):未确定
19. 溶解性:未确定
安全信息
- 外观与性状:
- 白色至奶油色结晶粉末
- 熔点:
- 102-104 °C(lit.)
- 沸点:
- 485.5ºC at 760 mmHg
- 闪点:
- 247.4ºC
- 水溶解性:
- 易溶
- 存储条件/存储方法:
保持容器密封,储存在阴凉,干燥的地方
- 稳定性相关:
常温常压下稳定,避免氧化物接触
- 其它信息:
1. 性状:未确定
2. 密度(g/mL,25/4℃):未确定
3. 相对蒸汽密度(g/mL,空气=1):未确定
4. 熔点(ºC):102-104°C
5. 沸点(ºC,常压):未确定
6. 沸点(ºC,5.2kPa):未确定
7. 折射率:未确定
8. 闪点(ºC):未确定
9. 比旋光度(º):未确定
10. 自燃点或引燃温度(ºC):未确定
11. 蒸气压(kPa,25ºC):未确定
12. 饱和蒸气压(kPa,60ºC):未确定
13. 燃烧热(KJ/mol):未确定
14. 临界温度(ºC):未确定
15. 临界压力(KPa):未确定
16. 油水(辛醇/水)分配系数的对数值:未确定
17. 爆炸上限(%,V/V):未确定
18. 爆炸下限(%,V/V):未确定
19. 溶解性:未确定
毒理性
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- UA0600000
- CHEMICAL NAME :
- 1,2,3-Propanetriol, 2-(dihydrogen phosphate), disodium salt
- CAS REGISTRY NUMBER :
- 819-83-0
- LAST UPDATED :
- 199701
- DATA ITEMS CITED :
- 4
- MOLECULAR FORMULA :
- C3-H9-O6-P.2Na
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Unreported
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 3400 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- GWXXBX German Offenlegungsschrift Patent Document. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #2502735 ** OTHER MULTIPLE DOSE TOXICITY DATA **
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 439 gm/kg/33W-C
- TOXIC EFFECTS :
- Liver - other changes Kidney, Ureter, Bladder - changes in bladder weight Biochemical - Metabolism (Intermediary) - lipids including transport
- REFERENCE :
- TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 8,115,1977 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X3980 No. of Facilities: 56 (estimated) No. of Industries: 1 No. of Occupations: 2 No. of Employees: 1359 (estimated) No. of Female Employees: 1127 (estimated)
- 生态数据:
对水是稍微有害的,不要让未稀释或大量的产品接触地下水,水道或者污水系统,若无政府许可,勿将材料排入周围环境
MSDS
Name: | beta-Glycerophosphoric acid disodium salt pentahydrate 98% (Titr.) Material Safety Data Sheet |
Synonym: | Disodium glycerol 2-phosphate; Sodium glycerophosphate |
CAS: | 819-83-0 |
Section 1 - Chemical Product MSDS Name:beta-Glycerophosphoric acid disodium salt pentahydrate 98% (Titr.) Material Safety Data Sheet
Synonym:Disodium glycerol 2-phosphate; Sodium glycerophosphate
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# | Chemical Name | content | EINECS# |
819-83-0 | beta-Glycerophosphoric acid disodium s | 98 | 212-464-3 |
Hazard Symbols: XI
Risk Phrases: 36/37/38
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. May be harmful if inhaled.
Chronic:
No information found.
Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation. Do not let this chemical enter the environment.
Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 819-83-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Crystalline powder
Color: white
Odor: Not available.
pH: 9.5 (50g/L @ 20C)
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 102-104C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C3H7Na2O6P.5H2O
Molecular Weight: 306.11
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids.
Hazardous Decomposition Products:
Carbon monoxide, oxides of phosphorus, carbon dioxide.
Hazardous Polymerization: Will not occur.
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 819-83-0: UA0600000 LD50/LC50:
Not available.
Carcinogenicity:
beta-Glycerophosphoric acid disodium salt, pentahydrate - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
Section 12 - ECOLOGICAL INFORMATION
Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - TRANSPORT INFORMATION
IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 819-83-0: No information available.
Canada
CAS# 819-83-0 is listed on Canada's DSL List.
CAS# 819-83-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 819-83-0 is listed on the TSCA inventory.
SECTION 16 - ADDITIONAL INFORMATION
N/A
海关数据
中国海关编码:2919900090
- 概述:
- HS:2919900090 其他磷酸酯及其盐(包括乳磷酸盐)(包括它们的卤化,磺化,硝化和亚硝化衍生物) 增值税率:17.0% 退税率:9.0% 监管条件:AB(入境货物通关单,出境货物通关单) 最惠国关税:6.5% 普通关税:30.0%
- 申报要素:
- 品名, 成分含量, 用途
- 监管条件:
- A.入境货物通关单B.出境货物通关单
- 检验检疫:
- R.进口食品卫生监督检验S.出口食品卫生监督检验M.进口商品检验N.出口商品检验
- 摘要/Summary:
- 2919900090 other phosphoric esters and their salts, including lactophosphates; their halogenated, sulphonated, nitrated or nitrosated derivatives。supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward)。VAT:17.0%。tax rebate rate:9.0%。MFN tariff:6.5%。general tariff:30.0%
分子结构与计算化学数据
计算化学数据
1、 氢键供体数量:2
2、 氢键受体数量:6
3、 可旋转化学键数量:3
4、 拓扑分子极性表面积(TPSA):113
5、 重原子数量:12
6、 表面电荷:0
7、 复杂度:117
8、 同位素原子数量:0
9、 确定原子立构中心数量:1
10、 不确定原子立构中心数量:0
11、 确定化学键立构中心数量:0
12、 不确定化学键立构中心数量:0
13、 共价键单元数量:3